The DOI matches its Crossref record; 219 of the 219 references it cites were found in a registry or an index.
Islet Amyloid: A Critical Entity in the Pathogenesis of Type 2 Diabetes
Abstract
Islet amyloid deposition is a pathogenic feature of type 2 diabetes, and these deposits contain the unique amyloidogenic peptide islet amyloid polypeptide. Autopsy studies in humans have demonstrated that islet amyloid is associated with loss of beta-cell mass, but a direct role for amyloid in the pathogenesis of type 2 diabetes cannot be inferred from such studies. Animal studies in both spontaneous and transgenic models of islet amyloid formation have shown that amyloid forms in islets before fasting hyperglycemia and therefore does not arise merely as a result of the diabetic state. Furthermore, the extent of amyloid deposition is associated with both loss of beta-cell mass and impairment in insulin secretion and glucose metabolism, suggesting a causative role for islet amyloid in the islet lesion of type 2 diabetes. These animal studies have also shown that beta-cell dysfunction seems to be an important prerequisite for islet amyloid formation, with increased secretory demand from obesity and/or insulin resistance acting to further increase islet amyloid deposition. Recent in vitro studies suggest that the cytotoxic species responsible for islet amyloid-induced beta-cell death are formed during the very early stages of islet amyloid formation, when islet amyloid polypeptide aggregation commences. Interventions to prevent islet amyloid formation are emerging, with peptide and small molecule inhibitors being developed. These agents could thus lead to a preservation of beta-cell mass and amelioration of the islet lesion in type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
Jarrett, J. T., & Lansbury, P. T. (1993) · Cell · doi:10.1016/0092-8674(93)90635-4 · Cited by 2,178
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
Weyer, C., Bogardus, C., Mott, D. M., & Pratley, R. E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7231 · Cited by 1,940
Common core structure of amyloid fibrils by synchrotron X-ray diffraction 1 1Edited by F. E. Cohen
Sunde, M., Serpell, L. C., Bartlam, M., Fraser, P. E., Pepys, M. B., & Blake, C. C. F. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1348 · Cited by 1,707
Schmechel, D. E., Saunders, A. M., Strittmatter, W. J., Crain, B. J., Hulette, C. M., Joo, S. H., Pericak-Vance, M. A., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9649 · Cited by 1,525
Kahn, S. E., Prigeon, R. L., McCulloch, D. K., Boyko, E. J., Bergman, R. N., Schwartz, M. W., Neifing, J. L., Ward, W. K., Beard, J. C., & Palmer, J. P. (1993) · Diabetes · doi:10.2337/diab.42.11.1663 · Cited by 1,405
Self-citationBeta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.
Lorenzo, A., & Yankner, B. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12243 · Cited by 1,324
Cooper, G. J., Willis, A. C., Clark, A., Turner, R. C., Sim, R. B., & Reid, K. B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.23.8628 · Cited by 1,299
Diet-Induced Type II Diabetes in C57BL/6J Mice
Surwit, R. S., Kuhn, C. M., Cochrane, C., McCubbin, J. A., & Feinglos, M. N. (1988) · Diabetes · doi:10.2337/diab.37.9.1163 · Cited by 1,208
Tiedge, M., Lortz, S., Drinkgern, J., & Lenzen, S. (1997) · Diabetes · doi:10.2337/diab.46.11.1733 · Cited by 1,208
ON THE BINDING OF CONGO RED BY AMYLOID
PUCHTLER, H., SWEAT, F., & LEVINE, M. (1962) · Journal of Histochemistry & Cytochemistry · doi:10.1177/10.3.355 · Cited by 1,128
Westermark, P., Wernstedt, C., Wilander, E., Hayden, D. W., O'Brien, T. D., & Johnson, K. H. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.11.3881 · Cited by 976
Self-citationImprovement in Glucose Tolerance and Insulin Resistance in Obese Subjects Treated with Troglitazone
Nolan, J. J., Ludvik, B., Beerdsen, P., Joyce, M., & Olefsky, J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411033311803 · Cited by 926
Insulin Degradation: Progress and Potential*
Duckworth, W. C., Bennett, R. G., & Hamel, F. G. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.5.0349 · Cited by 871
Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition
Bales, K. R., Verina, T., Dodel, R. C., Du, Y., Altstiel, L., Bender, M., Hyslop, P., Johnstone, E. M., Little, S. P., Cummins, D. J., et al. (1997) · Nature Genetics · doi:10.1038/ng1197-263 · Cited by 830
X-RAY DIFFRACTION STUDIES ON AMYLOID FILAMENTS
EANES, E. D., & GLENNER, G. G. (1968) · Journal of Histochemistry & Cytochemistry · doi:10.1177/16.11.673 · Cited by 823
Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus
Lorenzo, A., Razzaboni, B., Weir, G. C., & Yankner, B. A. (1994) · Nature · doi:10.1038/368756a0 · Cited by 820
Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation.
Westermark, P., Engström, U., Johnson, K. H., Westermark, G. T., & Betsholtz, C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.5036 · Cited by 807
Self-citationApolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid
Wisniewski, T., & Frangione, B. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90444-c · Cited by 802
Fibril in senile systemic amyloidosis is derived from normal transthyretin.
Westermark, P., Sletten, K., Johansson, B., & Cornwell, G. G. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.7.2843 · Cited by 696
Self-citationThe Importance of β-Cell Failure in the Development and Progression of Type 2 Diabetes
Kahn, S. E. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7713 · Cited by 660
Self-citationElectron Microscopic Observations on a Fibrous Component in Amyloid of Diverse Origins
COHEN, A. S., & CALKINS, E. (1959) · Nature · doi:10.1038/1831202a0 · Cited by 638
Janson, J., Ashley, R. H., Harrison, D., McIntyre, S., & Butler, P. C. (1999) · Diabetes · doi:10.2337/diabetes.48.3.491 · Cited by 612
Clark, A., Wells, C. A., BULEY, I. D., Cruickshank, J. K., Vanhegan, R. I., Matthews, D. R., Cooper, G. J. S., Holman, R. R., & Turner, R. C. (1988) · PubMed · Cited by 518
Westermark, P., Wernstedt, C., Wilander, E., & Sletten, K. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(86)90708-4 · Cited by 512
Self-citationVekrellis, K., Ye, Z., Qiu, W. Q., Walsh, D., Hartley, D., Chesneau, V., Rosner, M. R., & Selkoe, D. J. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-05-01657.2000 · Cited by 495
Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes.
Kahn, S. E., Andrikopoulos, S., & Verchere, C. B. (1999) · Diabetes · doi:10.2337/diabetes.48.2.241 · Cited by 488
Self-citationBales, K. R., Verina, T., Cummins, D. J., Du, Y., Dodel, R. C., Saura, J., Fishman, C. E., DeLong, C. A., Piccardo, P., Petegnief, V., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.15233 · Cited by 486
Leighton, B., & Cooper, G. J. S. (1988) · Nature · doi:10.1038/335632a0 · Cited by 473
Evidence of Cosecretion of Islet Amyloid Polypeptide and Insulin by β-Cells
Kahn, S. E., D'Alessio, D. A., Schwartz, M. W., Fujimoto, W. Y., Ensinck, J. W., Taborsky, G. J., & Porte, D. (1990) · Diabetes · doi:10.2337/diab.39.5.634 · Cited by 454
Self-citationPore Formation by the Cytotoxic Islet Amyloid Peptide Amylin
Mirzabekov, T. A., Lin, M.-C., & Kagan, B. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.4.1988 · Cited by 442
Rizza, R. A., Mandarino, L. J., & Gerich, J. E. (1982) · Diabetes · doi:10.2337/diab.31.8.663 · Cited by 440
Saraiva, M. J., Birken, S., Costa, P. P., & Goodman, D. S. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111390 · Cited by 434
Tenidis, K., Waldner, M., Bernhagen, J., Fischle, W., Bergmann, M., Weber, M., Merkle, M.-L., Voelter, W., Brunner, H., & Kapurniotu, A. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3422 · Cited by 426
Analysis of the Minimal Amyloid-forming Fragment of the Islet Amyloid Polypeptide
Azriel, R., & Gazit, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102883200 · Cited by 420
Shearman, M. S., Ragan, C. I., & Iversen, L. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.4.1470 · Cited by 412
HIGH-RESOLUTION ELECTRON MICROSCOPIC ANALYSIS OF THE AMYLOID FIBRIL
Shirahama, T., & Cohen, A. S. (1967) · The Journal of Cell Biology · doi:10.1083/jcb.33.3.679 · Cited by 383
Amyloid peptides are toxic via a common oxidative mechanism.
Schubert, D., Behl, C., Lesley, R., Brack, A., Dargusch, R., Sagara, Y., & Kimura, H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.6.1989 · Cited by 379
Lukinius, A., Wilander, E., Westermark, G. T., Engstr�m, U., & Westermark, P. (1989) · Diabetologia · doi:10.1007/bf00285291 · Cited by 371
Self-citationCHEN, M., BERGMAN, R. N., PACINI, G., & PORTE, D. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-1-13 · Cited by 353
Effects of Meal Ingestion on Plasma Amylin Concentration in NIDDM and Nondiabetic Humans
Butler, P. C., Chou, J., Carter, W. B., Wang, Y.-N., Bu, B.-H., Chang, D., Chang, J.-K., & Rizza, R. A. (1990) · Diabetes · doi:10.2337/diab.39.6.752 · Cited by 330
Insulin Degradation: Mechanisms, Products, and Significance*
DUCKWORTH, W. C. (1988) · Endocrine Reviews · doi:10.1210/edrv-9-3-319 · Cited by 313
Jensen, C. C., Cnop, M., Hull, R. L., Fujimoto, W. Y., Kahn, S. E., & the American Diabetes Association GENNID Study Group (2002) · Diabetes · doi:10.2337/diabetes.51.7.2170 · Cited by 312
Self-citationOpie, E. L. (1901) · Journal of Experimental Medicine · doi:10.1084/jem.5.5.527 · Cited by 305
Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology
Jaikaran, E. T. A. S., & Clark, A. (2001) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(01)00078-3 · Cited by 294
Anguiano, M., Nowak, R. J., & Lansbury, P. T. (2002) · Biochemistry · doi:10.1021/bi020314u · Cited by 293
Klebig, M. L., Wilkinson, J. E., Geisler, J. G., & Woychik, R. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.4728 · Cited by 291
The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus
Westermark, P., & Wilander, E. (1978) · Diabetologia · doi:10.1007/bf01219652 · Cited by 290
Self-citationVerchere, C. B., D'Alessio, D. A., Palmiter, R. D., Weir, G. C., Bonner-Weir, S., Baskin, D. G., & Kahn, S. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3492 · Cited by 278
Self-citationIn vitro autoradiographic localization of amylin binding sites in rat brain
Sexton, P. M., Paxinos, G., Kenney, M. A., Wookey, P. J., & Beaumont, K. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90388-3 · Cited by 277
Ward, W. K., LaCava, E. C., Paquette, T. L., Beard, J. C., Wallum, B. J., & Porte, D. (1987) · Diabetologia · doi:10.1007/bf00296991 · Cited by 275
Muff, R., Bühlmann, N., Fischer, J. A., & Born, W. (1999) · Endocrinology · doi:10.1210/endo.140.6.6930 · Cited by 273
Benditt, E. P., Eriksen, N., Hermodson, M. A., & Ericsson, L. H. (1971) · FEBS Letters · doi:10.1016/0014-5793(71)80506-9 · Cited by 269
Characterization of amyloid fibril proteins from medullary carcinoma of the thyroid.
Sletten, K., Westermark, P., & Natvig, J. B. (1976) · The Journal of experimental medicine · doi:10.1084/jem.143.4.993 · Cited by 265
Self-citationAn islet amyloid peptide is derived from an 89-amino acid precursor by proteolytic processing.
Sanke, T., Bell, G. I., Sample, C., Rubenstein, A. H., & Steiner, D. F. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)77825-9 · Cited by 258
Thioflavine T interaction with amyloid β-sheet structures
LeVine, H. (1995) · Amyloid · doi:10.3109/13506129509031881 · Cited by 253
The amyloid deposits in Alzheimer's disease: their nature and pathogenesis.
Glenner, G. G., Wong, C. W., Quaranta, V., & Eanes, E. D. (1984) · PubMed · Cited by 244
Marshall, J. A., Hoag, S., Shetterly, S., & Hamman, R. F. (1994) · Diabetes Care · doi:10.2337/diacare.17.1.50 · Cited by 244
Lutz, T. A., Senn, M., Althaus, J., Del Prete, E., Ehrensperger, F., & Scharrer, E. (1998) · Peptides · doi:10.1016/s0196-9781(97)00292-1 · Cited by 240
Jaikaran, E. T. A. S., Higham, C. E., Serpell, L. C., Zurdo, J., Gross, M., Clark, A., & Fraser, P. E. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4593 · Cited by 236
The Importance of -Cell Failure in the Development and Progression of Type 2 Diabetes
Kahn, S. E. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.9.4047 · Cited by 232
Self-citationKahn, S. E., & Halban, P. A. (1997) · Diabetes · doi:10.2337/diabetes.46.11.1725 · Cited by 221
Self-citationKahn, S. E., & Halban, P. A. (1997) · Diabetes · doi:10.2337/diab.46.11.1725 · Cited by 221
Self-citationProteoglycans in the pathogenesis of Alzheimer's disease and other amyloidoses
Snow, A. D., & Wight, T. N. (1989) · Neurobiology of Aging · doi:10.1016/0197-4580(89)90108-5 · Cited by 218
Amyloid Fibril Protein Nomenclature - 2002
(2002) · Amyloid · doi:10.3109/13506120209114823 · Cited by 217
Pepys, M. B., Rademacher, T. W., Amatayakul-Chantler, S., Williams, P., Noble, G. E., Hutchinson, W. L., Hawkins, P. N., Nelson, S. R., Gallimore, J. R., & Herbert, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5602 · Cited by 214
Westermark, P., Wilander, E., Westermark, G. T., & Johnson, K. H. (1987) · Diabetologia · doi:10.1007/bf00274799 · Cited by 208
Self-citationHigh affinity amylin binding sites in rat brain.
Beaumont, K., Kenney, M. A., Young, A. A., & Rink, T. J. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13212-4 · Cited by 208
Shearman, M. S., Hawtin, S. R., & Tailor, V. J. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65010218.x · Cited by 203
Effects of Sequential Proline Substitutions on Amyloid Formation by Human Amylin20-29
Moriarty, D. F., & Raleigh, D. P. (1999) · Biochemistry · doi:10.1021/bi981658g · Cited by 201
Effects of beta cell granule components on human islet amyloid polypeptide fibril formation
Westermark, P., Li, Z.-C., Westermark, G. T., Leckström, A., & Steiner, D. F. (1996) · FEBS Letters · doi:10.1016/0014-5793(95)01512-4 · Cited by 197
Self-citationJohnson, K. H., O’Brien, T. D., Hayden, D. W., Jordan, K., Ghobrial, H. K. G., Mahoney, W. C., & Westermark, P. (1988) · PubMed Central · Cited by 195
Self-citationHartter, E., Svoboda, T., Ludvik, B., Schuller, M., Lell, B., Kuenburg, E., Brunnbauer, M., Woloszczuk, W., & Prager, R. (1991) · Diabetologia · doi:10.1007/bf00404025 · Cited by 191
Ohsawa, H., Kanatsuka, A., Yamaguchi, T., Makino, H., & Yoshida, S. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92529-1 · Cited by 186
Hyperproinsulinemia and Amyloid in NIDDM: Clues to Etiology of Islet β-Cell Dysfunction?
Porte, D., & Kahn, S. E. (1989) · Diabetes · doi:10.2337/diab.38.11.1333 · Cited by 185
Self-citationAmyloid P component. A critical review
Pepys, M. B., Booth, D. R., Hutchinson, W. L., Gallimore, J. R., Collins, I. M., & Hohenester, E. (1997) · Amyloid · doi:10.3109/13506129709003838 · Cited by 181
Insulin-degrading enzyme: embarking on amyloid destruction
Kurochkin, I. V. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01876-x · Cited by 177
Anorexia following the intrahypothalamic administration of amylin
Chance, W. T., Balasubramaniam, A., Zhang, F. S., Wimalawansa, S. J., & Fischer, J. E. (1991) · Brain Research · doi:10.1016/0006-8993(91)91644-g · Cited by 177
Yoshioka, N., Kuzuya, T., Matsuda, A., Taniguchi, M., & Iwamoto, Y. (1988) · Diabetologia · doi:10.1007/bf02341503 · Cited by 175
Kapurniotu, A., Schmauder, A., & Tenidis, K. (2002) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.5244 · Cited by 175
Inhibition of Central Amylin Signaling Increases Food Intake and Body Adiposity in Rats
Rushing, P. A. (2001) · Endocrinology · doi:10.1210/en.142.11.5035 · Cited by 174
The Human Islet Amyloid Polypeptide Forms Transient Membrane-Active Prefibrillar Assemblies
Porat, Y., Kolusheva, S., Jelinek, R., & Gazit, E. (2003) · Biochemistry · doi:10.1021/bi034889i · Cited by 174
Quantitative Studies of Amyloid in the Islets of Langerhans
Westermark, P. (1972) · Upsala Journal of Medical Sciences · doi:10.1517/03009734000000014 · Cited by 170
Self-citationDegradation of Amylin by Insulin-degrading Enzyme
Bennett, R. G., Duckworth, W. C., & Hamel, F. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006170200 · Cited by 170
Disproportionately Elevated Proinsulin in Pima Indians with Noninsulin-Dependent Diabetes Mellitus*
SAAD, M. F., KAHN, S. E., NELSON, R. G., PETTITT, D. J., KNOWLER, W. C., SCHWARTZ, M. W., KOWALYK, S., BENNETT, P. H., & PORTE, D. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-5-1247 · Cited by 167
Self-citationMissense Mutation of Amylin Gene (S20G) in Japanese NIDDM Patients
Sakagashira, S., Sanke, T., Hanabusa, T., Shimomura, H., Ohagi, S., Kumagaye, K. Y., Nakajima, K., & Nanjo, K. (1996) · Diabetes · doi:10.2337/diab.45.9.1279 · Cited by 167
de Koning, E. J. P., Bodkin, N. L., Hansen, B. C., & Clark, A. (1993) · Diabetologia · doi:10.1007/bf00402271 · Cited by 167
Tilakaratne, N., Christopoulos, G., Zumpe, E. T., Foord, S. M., & Sexton, P. M. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39040-8 · Cited by 165
Circular-dichroism studies on two murine serum amyloid A proteins
McCubbin, W. D., Kay, C. M., Narindrasorasak, S., & Kisilevsky, R. (1988) · Biochemical Journal · doi:10.1042/bj2560775 · Cited by 165
Increased Insulin Secretion and Glucose Tolerance in Mice Lacking Islet Amyloid Polypeptide (Amylin)
Gebre-Medhin, S., Mulder, H., Pekny, M., Westermark, G., Törnell, J., Westermark, P., Sundler, F., Ahrén, B., & Betsholtz, C. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9308 · Cited by 157
Self-citationSakagashira, S., Hiddinga, H. J., Tateishi, K., Sanke, T., Hanabusa, T., Nanjo, K., & Eberhardt, N. L. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64848-1 · Cited by 156
Johnson, A. B., Webster, J. M., Sum, C. F., Heseltine, L., Argyraki, M., Cooper, B. G., & Taylor, R. (1993) · Metabolism · doi:10.1016/0026-0495(93)90284-u · Cited by 154
Höppener, J. W. M., Oosterwijk, C., Nieuwenhuis, M. G., Posthuma, G., Thijssen, J. H. H., Vroom, T. M., Ahrén, B., & Lips, C. J. M. (1999) · Diabetologia · doi:10.1007/s001250051175 · Cited by 153
Roberts, A. N., Leighton, B., Todd, J. A., Cockburn, D. J., Schofield, P. N., Sutton, R., Holt, S., Boyd, Y., Day, A. J., & FOOT, E. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.24.9662 · Cited by 150
Nilsson, M. R., & Raleigh, D. P. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3286 · Cited by 150
Sanke, T., Hanabusa, T., Nakano, Y., Oki, C., Okai, K., Nishimura, S., Kondo, M., & Nanjo, K. (1991) · Diabetologia · doi:10.1007/bf00500385 · Cited by 149
Samsom, M., Szarka, L. A., Camilleri, M., Vella, A. V., Zinsmeister, A. R., & Rizza, R. A. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.278.6.g946 · Cited by 148
Structural Characterisation of Islet Amyloid Polypeptide Fibrils
Makin, O. S., & Serpell, L. C. (2003) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.11.048 · Cited by 147
Design of Peptide-based Inhibitors of Human Islet Amyloid Polypeptide Fibrillogenesis
Scrocchi, L. A., Chen, Y., Waschuk, S., Wang, F., Cheung, S., Darabie, A. A., McLaurin, J., & Fraser, P. E. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00164-x · Cited by 145
Bennett, D. L., BAILYES, E. M., Nielsen, E.-M. D., Guest, P. C., Rutherford, N. G., Arden, S. D., & Hutton, J. C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42170-9 · Cited by 144
Longitudinal studies on the development of diabetes in individual Macaca nigra
Howard, C. F. (1986) · Diabetologia · doi:10.1007/bf00452067 · Cited by 141
Islet amyloid-associated diabetes in obese A(vy)/a mice expressing human islet amyloid polypeptide.
Soeller, W. C., Janson, J., Hart, S. E., Parker, J. C., Carty, M. D., Stevenson, R. W., Kreutter, D. K., & Butler, P. C. (1998) · Diabetes · doi:10.2337/diabetes.47.5.743 · Cited by 140
Proinsulin as a marker for the development of NIDDM in Japanese-American men
Kahn, S. E., Leonetti, D. L., Prigeon, R. L., Boyko, E. J., Bergstrom, R. W., & Fujimoto, W. Y. (1995) · Diabetes · doi:10.2337/diabetes.44.2.173 · Cited by 138
Self-citationProinsulin as a Marker for the Development of NIDDM in Japanese-American Men
Kahn, S. E., Leonetti, D. L., Prigeon, R. L., Boyko, E. J., Bergstrom, R. W., & Fujimoto, W. Y. (1995) · Diabetes · doi:10.2337/diab.44.2.173 · Cited by 138
Self-citationBAILYES, E. M., SHENNAN, K. I. J., Seal, A., Smeekens, S. P., Steiner, D. F., Hutton, J. C., & Docherty, K. (1992) · Biochemical Journal · doi:10.1042/bj2850391 · Cited by 136
Heparin-binding Properties of the Amyloidogenic Peptides Aβ and Amylin
Watson, D. J., Lander, A. D., & Selkoe, D. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31617 · Cited by 135
Infusion of pramlintide, a human amylin analogue, delays gastric emptying in men with IDDM
Kong, M.-F., King, P., Macdonald, I. A., Stubbs, T. A., Perkins, A. C., Blackshaw, P. E., Moyses, C., & Tattersall, R. B. (1997) · Diabetologia · doi:10.1007/s001250050646 · Cited by 131
May, P. C., Boggs, L. N., & Fuson, K. S. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb07480.x · Cited by 131
Castillo, G. M., Cummings, J. A., Yang, W. J., Judge, M. E., Sheardown, M. J., Rimvall, K., Hansen, J., & Snow, A. D. (1998) · Diabetes · doi:10.2337/diabetes.47.4.612 · Cited by 130
Bennett, R. G., Hamel, F. G., & Duckworth, W. C. (2003) · Diabetes · doi:10.2337/diabetes.52.9.2315 · Cited by 127
Betsholtz, C., Svensson, V., Rorsman, F., Engström, U., Westermark, G. T., Wilander, E., Johnson, K. H., & Westermark, P. (1989) · Experimental Cell Research · doi:10.1016/0014-4827(89)90407-2 · Cited by 125
Self-citationBody Fat Distribution in Healthy Young and Older Men
Schwartz, R. S., Shuman, W. P., Bradbury, V. L., Cain, K. C., Fellingham, G. W., Beard, J. C., Kahn, S. E., Stratton, J. R., Cerqueira, M. D., & Abrass, I. B. (1990) · Journal of Gerontology · doi:10.1093/geronj/45.6.m181 · Cited by 124
Self-citationComparison of the Effects of Calcitonin Gene-Related Peptide and Amylin on Osteoblasts
Dr. Cornish, J., Callon, K. E., Lin, C. Q., Xiao, C. L., Gamble, G. D., Cooper, G. J. S., & Reid, I. R. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.8.1302 · Cited by 121
Islet amyloid polypeptide in diabetic and non-diabetic Pima Indians
Clark, A., Saad, M. F., Nezzer, T., Uren, C., Knowler, W. C., Bennett, P. H., & Turner, R. C. (1990) · Diabetologia · doi:10.1007/bf00403322 · Cited by 119
Enoki, S., Mitsukawa, T., Takemura, J., Nakazato, M., Aburaya, J., Toshimori, H., & Matsukara, S. (1992) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(92)90074-2 · Cited by 118
Oliver, K. R., Kane, S. A., Salvatore, C., Mallee, J. J., Kinsey, A. M., Koblan, K. S., Keyvan‐Fouladi, N., HEAVENS, R. P., Wainwright, A., Jacobson, M. A., et al. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01688.x · Cited by 118
Kelńyi, G. (1967) · Acta Neuropathologica · doi:10.1007/bf00688089 · Cited by 117
Replication Increases β-Cell Vulnerability to Human Islet Amyloid Polypeptide-Induced Apoptosis
Ritzel, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.7.1701 · Cited by 115
Role of β-Cell Prohormone Convertase (PC)1/3 in Processing of Pro-Islet Amyloid Polypeptide
Marzban, L., Trigo‐Gonzalez, G., Zhu, X., Rhodes, C. J., Halban, P. A., Steiner, D. F., & Verchere, C. B. (2004) · Diabetes · doi:10.2337/diabetes.53.1.141 · Cited by 113
Jaikaran, E. T. A. S., Nilsson, M. R., & Clark, A. (2004) · Biochemical Journal · doi:10.1042/bj20030852 · Cited by 112
The Mechanism of Insulin Action on Islet Amyloid Polypeptide Fiber Formation
Larson, J. L., & Miranker, A. D. (2003) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.10.045 · Cited by 112
Clark, A., Edwards, C., Ostle, L., Sutton, R., Rothbard, J., Morris, J., & Turner, R. (1989) · Cell and Tissue Research · doi:10.1007/bf00221649 · Cited by 112
Wang, J., Xu, J., Finnerty, J., Furuta, M., Steiner, D. F., & Verchere, C. B. (2001) · Diabetes · doi:10.2337/diabetes.50.3.534 · Cited by 112
Contribution of advanced glycosylation to the amyloidogenicity of islet amyloid polypeptide
Kapurniotu, A., Bernhagen, J., Greenfield, N. J., Al‐Abed, Y., Teichberg, S., Frank, R. W., Voelter, W., & Bucala, R. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2510208.x · Cited by 111
Diet of second-generation Japanese-American men with and without non-insulin-dependent diabetes
Tsunehara, C. H., Leonetti, D., & Fujimoto, W. (1990) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/52.4.731 · Cited by 110
Johnson, K. H., O’Brien, T. D., Jordan, K., & Westermark, P. (1989) · PubMed Central · Cited by 109
Self-citationPark, K., & Verchere, C. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008423200 · Cited by 109
Hull, R. L., Andrikopoulos, S., Verchere, C. B., Vidal, J., Wang, F., Cnop, M., Prigeon, R. L., & Kahn, S. E. (2003) · Diabetes · doi:10.2337/diabetes.52.2.372 · Cited by 109
Self-citationBeard, J. C., Halter, J. B., Best, J. D., Pfeifer, M. A., & Porte, D. (1984) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1984.247.5.e592 · Cited by 109
Hyalinization of the islets of Langerhans in nondiabetic individuals.
BELL, E. T. (1959) · PubMed · Cited by 106
Mykkänen, L., Haffner, S. M., Hales, C., Rönnemaa, T., & Laakso, M. (1997) · Diabetes · doi:10.2337/diab.46.12.1990 · Cited by 101
Amylin inhibits bone resorption by a direct effect on the motility of rat osteoclasts
Alam, A., Moonga, B., Bevis, P., Huang, C., & Zaidi, M. (1993) · Experimental Physiology · doi:10.1113/expphysiol.1993.sp003679 · Cited by 99
Nishi, M., Sanke, T., Seino, S., Eddy, R. L., Fan, Y., Byers, M. G., Shows, T. B., Bell, G. I., & Steiner, D. F. (1989) · Molecular Endocrinology · doi:10.1210/mend-3-11-1775 · Cited by 99
Amyloid and polypeptide hormones: What is their interrelationship?
Westermark, P. (1994) · Amyloid · doi:10.3109/13506129409148624 · Cited by 98
Self-citationIslet amyloid polypeptide amide causes peripheral insulin resistance in vivo in dogs
Sowa, R., Sanke, T., Hirayama, J., Tabata, H., Furuta, H., Nishimura, S., & Nanjo, K. (1990) · Diabetologia · doi:10.1007/bf00401051 · Cited by 98
A Feline Model of Experimentally Induced Islet Amyloidosis
Hoenig, M. E., Hall, G. A., Ferguson, D. C., Jordan, K., Henson, M. S., Johnson, K. H., & O’Brien, T. D. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64852-3 · Cited by 94
Rapid deposition of amyloid in human islets transplanted into nude mice
Westermark, P., Eizirik, D. L., PIPELEERS, D. G., Hellerstr�m, C., & Andersson, A. (1995) · Diabetologia · doi:10.1007/bf00400722 · Cited by 93
Self-citationPancreatic Expression and Secretion of Human Islet Amyloid Polypeptide in a Transgenic Mouse
D’Alessio, D. A., Verchere, C. B., Kahn, S. E., Hoagland, V. D., Baskin, D. G., Palmiter, R. D., & Ensinck, J. W. (1994) · Diabetes · doi:10.2337/diab.43.12.1457 · Cited by 93
Self-citationKaiyala, K. J., Prigeon, R. L., Kahn, S. E., Woods, S. C., Porte, D., & Schwartz, M. W. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.4.e659 · Cited by 93
Self-citationMykkanen, L., Haffner, S. M., Hales, C. N., Ronnemaa, T., & Laakso, M. (1997) · Diabetes · doi:10.2337/diabetes.46.12.1990 · Cited by 92
Young, I. D., Ailles, L., Narindrasorasak, S., Tan, R., & Kisilevsky, R. (1992) · PubMed · Cited by 92
Couce, M., Kane, L. A., O’Brien, T. D., Charlesworth, J. E., Soeller, W. C., McNeish, J. D., Kreutter, D. K., Roche, P. C., & Butler, P. C. (1996) · Diabetes · doi:10.2337/diab.45.8.1094 · Cited by 91
Tomiyama, T., Kaneko, H., Kataoka, K.-I., Asano, S., & Endo, N. (1997) · Biochemical Journal · doi:10.1042/bj3220859 · Cited by 91
The demonstration of vasodilator activity of pancreatic amylin amide in the rabbit.
Brain, S. D., Wimalawansa, S. J., MacIntyre, I. M., & Williams, T. J. (1990) · Europe PMC (PubMed Central) · Cited by 89
Effect of pH and insulin on fibrillogenesis of islet amyloid polypeptide in vitro
CHARGÉ, S. B. P., de Koning, E. J. P., & Clark, A. (1995) · Biochemistry · doi:10.1021/bi00044a038 · Cited by 89
Silvestre, R. A., Peiró, E., Dégano, P., Miralles, P., & Marco, J. (1990) · Regulatory Peptides · doi:10.1016/0167-0115(90)90192-y · Cited by 87
Dégano, P., Silvestre, R. A., Salas, M., Peiró, E., & Marco, J. (1993) · Regulatory Peptides · doi:10.1016/0167-0115(93)90411-z · Cited by 86
Fox, N. W., Schrementi, J. P., Nishi, M., Ohagi, S., Chan, S. J., Heisserman, J. A., Westermark, G. T., Leckström, A., Westermark, P., & Steiner, D. F. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81444-5 · Cited by 86
Self-citationDecrease of Stimulated Amylin Release Precedes Impairment of Insulin Secretion in Type II Diabetes
Ludvik, B., Lell, B., Hartter, E., Schnack, C., & Prager, R. (1991) · Diabetes · doi:10.2337/diab.40.12.1615 · Cited by 82
Åkesson, B., Panagiotidis, G., Westermark, P., & Lundquist, I. (2003) · Regulatory Peptides · doi:10.1016/s0167-0115(02)00252-5 · Cited by 82
Self-citationHöppener, J. W. M., Verbeek, J. S., de Koning, E. J. P., Oosterwijk, C., van Hulst, K. L., Visser-Vernooy, H. J., Hofhuis, F. M., van Gaalen, S., Berends, M. J. H., Hackeng, W. H. L., et al. (1993) · Diabetologia · doi:10.1007/bf00400803 · Cited by 81
Anorexia following the systemic injection of amylin
Chance, W. T., Balasubramaniam, A., Stallion, A., & Fischer, J. E. (1993) · Brain Research · doi:10.1016/0006-8993(93)91505-m · Cited by 79
Kolterman, O., Gottlieb, A., Moyses, C., & Colburn, W. A. (1995) · Diabetes Care · doi:10.2337/diacare.18.8.1179 · Cited by 79
Islet amyloid polypeptide (IAPP) and pro-IAPP immunoreactivity in human islets of Langerhans
Westermark, P., Engström, U., Westermark, G. T., Johnson, K. H., Permerth, J., & Betsholtz, C. (1989) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(89)90008-9 · Cited by 78
Self-citationWang, F., Hull, R. L., Vidal, J., Cnop, M., & Kahn, S. E. (2001) · Diabetes · doi:10.2337/diabetes.50.11.2514 · Cited by 77
Self-citationJanciauskiene, S. M., & Åhrén, B. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1989 · Cited by 76
Kahn, S. E., Verchere, C. B., Andrikopoulos, S., Asberry, P. J., Leonetti, D. L., Wahl, P. W., Boyko, E. J., Schwartz, R. S., Newell-Morris, L., & Fujimoto, W. Y. (1998) · Diabetes · doi:10.2337/diabetes.47.4.640 · Cited by 74
Self-citationB Cell Granule Peptides Affect Human Islet Amyloid Polypeptide (IAPP) Fibril Formationin Vitro
Janciauskiene, S. M., Eriksson, S., Carlemalm, E., & Åhrén, B. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7014 · Cited by 73
Role of islet amyloid polypeptide secretion in insulin-resistant humans
Kautzky‐Willer, A., Thomaseth, K., Pacini, G., Clodi, M., Ludvik, B. H., Streli, C., Waldhäusl, W. K., & Prager, R. (1994) · Diabetologia · doi:10.1007/s001250050092 · Cited by 72
Zhang, S., Liu, J., Saafi, E. L., & Cooper, G. J. S. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00894-7 · Cited by 71
Westermark, G. T., Gebré‐Medhin, S., Steiner, D. F., & Westermark, P. (2000) · Molecular Medicine · doi:10.1007/bf03402051 · Cited by 69
Self-citationThomas, R. G., Peterson, J. T., Gottlieb, A., & Mullane, J. F. (1997) · Diabetes · doi:10.2337/diab.46.4.632 · Cited by 67
Regulation of Islet Amyloid Polypeptide in Human Pancreatic Islets
Novials, A., Sarri, Y., Casamitjana, R., Rivera, F., & Gomis, R. (1993) · Diabetes · doi:10.2337/diab.42.10.1514 · Cited by 67
Novel Glycosaminoglycan Precursors as Anti-Amyloid Agents, Part III
Kisilevsky, R., Szarek, W. A., Ancsin, J. B., Bhat, S., Li, Z., & Marone, S. (2003) · Journal of Molecular Neuroscience · doi:10.1385/jmn:20:3:291 · Cited by 66
Saafi, E. L., Konarkowska, B., Zhang, S., Kistler, J., & Cooper, G. J. S. (2001) · Cell Biology International · doi:10.1006/cbir.2000.0643 · Cited by 65
Enhancedin vitroproduction of amyloid-like fibrils from mutant (S20G) islet amyloid polypeptide
Ma, Z., Westermark, G. T., Sakagashira, S., Sanke, T., Gustavsson, Å., Sakamoto, H., Engström, U., Nanjo, K., & Westermark, P. (2001) · Amyloid · doi:10.3109/13506120108993820 · Cited by 63
Self-citationProcessing of pro‐islet amyloid polypeptide (proIAPP) by the prohormone convertase PC2
Badman, M. K., SHENNAN, K. I. J., Jermany, J. L., Docherty, K., & Clark, A. (1996) · FEBS Letters · doi:10.1016/0014-5793(95)01460-8 · Cited by 62
Kahn, S. E., Larson, V., Schwartz, R. S., Beard, J. C., Cain, K. C., Fellingham, G. W., Stratton, J. R., Cerqueira, M., & Abrass, I. B. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.74.6.1592879 · Cited by 61
Self-citationTucker, H. M., Rydel, R. E., Wright, S., & Estus, S. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71020506.x · Cited by 59
Thompson, R., Peterson, J., Gottlieb, A., & Mullane, J. (1997) · Diabetes · doi:10.2337/diabetes.46.4.632 · Cited by 58
[44] Insulysin and pitrilysin: Insulin-degrading enzymes of mammals and bacteria
Becker, A. B., & Roth, R. A. (1995) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(95)48046-3 · Cited by 56
CHARGÉ, S. B. P., Esiri, M. M., Bethune, C., HANSEN, B. C., & Clark, A. (1996) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199608)179:4<443::aid-path612>3.0.co;2-7 · Cited by 56
Human aging is associated with parallel reductions in insulin and amylin release
Dechenes, C. J., Verchere, C. B., Andrikopoulos, S., & Kahn, S. E. (1998) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1998.275.5.e785 · Cited by 56
Self-citationAmylin binding in rat renal cortex, stimulation of adenylyl cyclase, and activation of plasma renin
Wookey, P. J., Tikellis, C., Du, H. C., Qin, H., Sexton, P. M., & Cooper, M. E. (1996) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1996.270.2.f289 · Cited by 56
Higham, C., Hull, R. L., Lawrie, L. C., SHENNAN, K. I. J., Morris, J. F., Birch, N. P., Docherty, K., & Clark, A. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01548.x · Cited by 55
Self-citationHasbak, P., Opgaard, O. S., Eskesen, K., Schifter, S., Arendrup, H. C., Longmore, J., & Edvinsson, L. I. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.037754 · Cited by 54
Yagui, K., Yamaguchi, T., Kanatsuka, A., Shimada, F., Huang, C. I., Tokuyama, Y., Ohsawa, H., Yamamura, K., Miyazaki, J., Mikata, A., et al. (1995) · European Journal of Endocrinology · doi:10.1530/eje.0.1320487 · Cited by 53
Serum amyloid P component enhances induction of murine amyloidosis.
Togashi, S., Lim, S. K., Kawano, H., Ito, S., Ishihara, T., Okada, Y., Nakano, S., Kinoshita, T., Horie, K., Episkopou, V., et al. (1997) · PubMed · Cited by 52
Knowles, N. G., Landchild, M. A., Fujimoto, W. Y., & Kahn, S. E. (2002) · Diabetes Care · doi:10.2337/diacare.25.2.292 · Cited by 51
Self-citationElevated Islet Amyloid Pancreatic Polypeptide and Proinsulin in Lean Gestational Diabetes
Kautzky‐Willer, A., Thomaseth, K., Ludvik, B. H., Nowotny, P., Rabensteiner, D., Waldhäusl, W., Pacini, G., & Prager, R. (1997) · Diabetes · doi:10.2337/diab.46.4.607 · Cited by 51
Hanabusa, T., Kubo, K., Oki, C., Nakano, Y., Okai, K., Sanke, T., & Nanjo, K. (1992) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(92)90073-z · Cited by 51
Chin, S. Y., Hall, J. M., Brain, S. D., et al. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38903-2 · Cited by 51
Harroun, T. A., Bradshaw, J. P., & Ashley, R. H. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02972-6 · Cited by 50
Role of Ca2+ in apoptosis evoked by human amylin in pancreatic islet beta-cells.
Bai, J., Saafi, E. L., Zhang, S., & Cooper, G. J. S. (1999) · PubMed Central · Cited by 47
Integrated mathematical model to assess beta-cell activity during the oral glucose test
Thomaseth, K., Kautzky‐Willer, A., Ludvik, B. H., Prager, R., & Pacini, G. (1996) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1996.270.3.e522 · Cited by 47
Amylin stimulates proximal tubular sodium transport and cell proliferation in the rat kidney
Harris, P. J., Cooper, M. E., Hiranyachattada, S., Berka, J. L., Kelly, D. J., Nobes, M., & Wookey, P. J. (1997) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1997.272.1.f13 · Cited by 47
Amyloidogenicity of recombinant human pro-islet amyloid polypeptide (ProIAPP)
Krampert, M., Bernhagen, J., Schmucker, J., Horn, A., Schmauder, A., Brunner, H., Voelter, W., & Kapurniotu, A. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00034-x · Cited by 45
Andrikopoulos, S., Verchere, C. B., Terauchi, Y., Kadowaki, T., & Kahn, S. E. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2056 · Cited by 44
Self-citationPro Islet Amyloid Polypeptide (ProIAPP) Immunoreactivity in the Islets of Langerhans
Westermark, G., Steiner, D., Gebre-Medhin, S., Engström, U., & Westermark, P. (2000) · Upsala Journal of Medical Sciences · doi:10.1517/03009734000000057 · Cited by 42
Self-citationHuman Islet Amyloid Polypeptide Accumulates at Similar Sites in Islets of Transgenic Mice and Humans
de Koning, E. J. P., Höppener, J. W. M., Verbeek, J. S., Oosterwijk, C., van Hulst, K. L., Baker, C. A., Lips, C. J. M., Morris, J. F., & Clark, A. (1994) · Diabetes · doi:10.2337/diab.43.5.640 · Cited by 42
Proteoglycans synthesized and secreted by pancreatic islet β-cells bind amylin
Potter‐Perigo, S., Hull, R. L., Tsoi, C., Braun, K. R., Andrikopoulos, S., Teague, J. C., Verchere, C. B., Kahn, S. E., & Wight, T. N. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(03)00116-4 · Cited by 41
Self-citationGilbey, S. G., Ghatei, M. A., Bretherton-Watt, D., Zaidi, M., Jones, P. M., Perera, T., Beacham, J., Girgis, S., & Bloom, S. R. (1991) · Clinical Science · doi:10.1042/cs0810803 · Cited by 39
Janciauskiene, S. M., & Åhrén, B. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9574 · Cited by 39
Westermark, G. T., Westermark, P., Eizirik, D. L., Hellerström, C., Fox, N. W., Steiner, D. F., & Andersson, A. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90102-6 · Cited by 37
Self-citation
Cited by
Type 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737
Type 2 diabetes: principles of pathogenesis and therapy
Stumvoll, M., Goldstein, B. J., & van Haeften, T. W. (2005) · The Lancet · doi:10.1016/s0140-6736(05)61032-x · Cited by 2,662
Biological and Chemical Approaches to Diseases of Proteostasis Deficiency
Powers, E. T., Morimoto, R. I., Dillin, A., Kelly, J. W., & Balch, W. E. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.052308.114844 · Cited by 1,149
Islet Amyloid Polypeptide, Islet Amyloid, and Diabetes Mellitus
Westermark, P., Andersson, A., & Westermark, G. T. (2011) · Physiological Reviews · doi:10.1152/physrev.00042.2009 · Cited by 1,044
Self-citationProtein aggregation diseases: pathogenicity and therapeutic perspectives
Aguzzi, A., & O'Connor, T. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3050 · Cited by 762
Metadata
- Authors
- Hull, R. L., Westermark, G. T., Westermark, P., & Kahn, S. E.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2004-08
- Volume
- 89
- Issue
- 8
- Pages
- 3629-3643
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2136989779
- Cited by
- 583
- References
- 219
- FWCI
- 16.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.